Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0000914190-20-000167

Pres. Diagnostics & Genom gave up 821 shares (to pay taxes)

  • Pres. Diagnostics & Genom acquired 1,666 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2020-05-01 Option exercise +1,666 2,489 D: show line 1 in the form
Kelderman Kim Pres. Diagnostics & Genom 2020-05-01 Shares withheld for taxes −821 $227.54 $186,810 1,668 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Pres. Diagnostics & Genom 2020-05-01 Option exercise · Restricted Stock Units −1,666 1,667 D: show line 3 in the form
Loading xslF345X03/edgar.xml…